Fishy Whales
Security

HALO · Halozyme Therapeutics, Inc.

40 institutional holder(s) · 3 congressional trade(s)
← Funds
Halozyme Therapeutics, Inc. is a company in the Health Care sector, identified from SEC filings. It is traded by 1 member of Congress in disclosed filings.

Institutional holders

13F
FundValueShares
Vanguard Group $717M10,653,115
BlackRock $531.8M8,229,039
State Street $319.1M4,937,854
BlackRock $227M3,512,989
Geode Capital Management $134.1M2,073,937
Bank of America $120.7M1,868,058
Two Sigma Investments $102.4M1,584,961
Vanguard Group $49.4M734,316
Morgan Stanley $49.2M761,940
Renaissance Technologies $47.3M731,811
Morgan Stanley $39.7M613,886
Morgan Stanley $38.4M594,774
Millennium Management $37.1M28,923,000
Bridgewater Associates $33.1M511,429
Citadel Advisors $32.3M25,092,000
Millennium Management $30.5M471,284
BlackRock $29.4M454,602
Geode Capital Management $27.9M431,849
Bank of America $24.1M373,407
Morgan Stanley $24.1M372,271
Bank of America $22.3M344,627
Citadel Advisors $20.3M19,455,000
BlackRock $17.4M269,115
BlackRock $17.3M268,174
BlackRock $14.2M219,539
State Street $11.7M9,038,000
Bank of America $10.9M168,769
Bank of America $10M154,037
BlackRock $9.8M7,625,000
BlackRock $7.4M114,643
Citadel Advisors $7M107,870
Vanguard Group $6.7M99,809
Fidelity $6.6M5,154,000
Morgan Stanley $5.9M91,079
Citadel Advisors $5.4M83,181
BlackRock $5.3M81,969
Vanguard Group $3.4M50,468
Citadel Advisors $3.1M48,000
Morgan Stanley $3.1M47,717
Morgan Stanley $3.1M2,400,000

Congressional trades

STOCK Act
MemberTypeDate
Josh Gottheimer sell 09/09/2024
Josh Gottheimer sell 12/06/2022
Josh Gottheimer sell 08/05/2022